A Multifaceted Nurse-based Strategy Reduces HEart FaiLure Morbidity in PatiENts Admitted for Acute Decompensated Heart Failure in Brazil
HELEN II
1 other identifier
interventional
252
1 country
1
Brief Summary
The home based intervention is a multidisciplinary approach that has shown benefit in the follow-up of patients with Heart Failure (HF). It is considered one of the most effective approaches and humanized by education and care for the patient in his environment of routine. In this study the monitoring of HF patients in the home after hospital discharge will include the reinforcement, monitoring and reassessment of previously provided guidance on the disease and self-care, compliance to prescribed medications and especially the early recognition of signs and symptoms of decompensation by patients and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started Aug 2009
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 9, 2009
CompletedFirst Posted
Study publicly available on registry
October 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJanuary 3, 2014
January 1, 2014
4.3 years
November 9, 2009
January 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome was a composite end-point of a first visit to the emergency department (lasting less than 24 hours), or a first hospital readmission (> 24h) or all-cause death, assessed during the first 6 months of follow-up.
This primary outcomes will be measured at each visit, which will have different intervals, according to the research protocol, with a final evaluation after the last home visit. Home visits (HV): 7 days after discharge, 15 days after 1st phone call (PC), 30 days after 2nd PC, 30 days after 3rd PC. Phone calls (PC): 7-10 days after 1st HV, 30 days after 2nd HV, 30 days after 3rd HV, 15 days after 4th HV. All patients come to Hospital evaluation after the 4th phone call.
Up to 36 months.
Secondary Outcomes (2)
Cost-effectiveness of visits to the emergency department and length of hospitalization.
up to 36 months
The secondary outcomes were each individual end-points
36 months
Study Arms (2)
Experimental: Intervention and control
EXPERIMENTALI: Experimental Routine monitoring by health team in the reference institution, four home visits and four telephone contacts with trained nurses. II: Control Routine monitoring by health team in the reference institution.
Control
NO INTERVENTIONInterventions
There will provided education about what is heart failure, its causes, how to recognize signs and symptoms, monitoring of weight and blood pressure, the importance of compliance to treatment. Patients will be instructed about the medications; a guide to rest and exercise, sexual activity, vaccines, travel and diet will be provided. The involvement of the family will be encouraged; the contact with the team should be done when: patient observes an increase of 1 or 2 kg of weight in 2-3 days, worsening of dyspnea on effort, edema in legs / abdomen, worsening of cough, persistent vomiting, syncope,sputum with blood, fever, persistent tachycardia. In phone calls made between home visits, the compliance to treatment will be evaluated and reinforced.
Eligibility Criteria
You may qualify if:
- Patients of both sexes, aged 18 years or above, with a diagnosis of heart failure with systolic dysfunction (ejection fraction ≤ 45%), hospitalized for decompensation of HF
- Who agree to participate in the study by signing the Informed Consent.
You may not qualify if:
- Patients with communication disabilities and people with degenerative neurological diseases.
- Are also excluded patients who presented acute coronary syndrome (ACS) in the last 6 months before randomization
- Patients with renal, hepatic, pulmonary or systemic disease that may confuse the interpretation of the findings or result in limited life expectancy
- Surgical plan or therapeutic that might influence the follow-up
- Pregnancy, diagnosis of acute heart failure secondary to:
- sepsis
- myocarditis
- myocardial infarction
- acute peripartum and other cause
- Have no interest in receiving home visits
- Living at a distance greater than 10 km from the hospital of origin
- Not be able to contact by telephone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal do Rio Grande do Sul - Post Graduated Program
Porto Alegre, Rio Grande do Sul, 90035003, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eneida R Rabelo da Silva, RN, ScD
HCPA and UFRGS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor; PhD.
Study Record Dates
First Submitted
November 9, 2009
First Posted
October 4, 2010
Study Start
August 1, 2009
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
January 3, 2014
Record last verified: 2014-01